$SLS News Article - SELLAS Life Sciences Receives
Post# of 88
(Total Views: 113)
Posted On: 01/09/2024 12:45:49 PM
$SLS News Article - SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients https://marketwirenews.com/news-releases/sell...28865.html
(0)
(0)SELLAS Life Sciences Group, Inc. (SLS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼